Open
SectorHealthcare
15.99 -0.74
24h
Min
16.04
Max
16.26
Income | -22M -274M |
---|---|
Sales | -5.4M 2.2M |
Profit margin | -12,622.627 |
Employees | 750 |
EBITDA | -284K -284M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +24.91% upside |
Market Cap | 3.5B 11B |
---|---|
Previous open | 16.73 |
Previous close | 15.99 |
By Acuity
50%
50%
183 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 20.31 USD 24.91%
High 24 USD
Low 16 USD
Based on 8 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$